M Q1 2026 Earnings EPS Beats Estimates by 673 as Stock Declines RLI Q1 2026 Earnings EPS Beats by Nearly 5 as Underwriting Disciplines Deliver AEON Biopharma Inc AEON Q4 2025 Earnings Significant EPS Miss and Stock Decline Amid Development Challenges GLMD Q4 2025 Earnings EPS Misses Estimates Amid Development Stage Uncertainty AMWL Q1 2026 Earnings EPS Beats Estimates by Wide Margin as Cost Controls Drive Improvement NEGG Q4 2022 Earnings Sharp EPS Miss Overshadows Modest Stock Uptick